GENELUX CORPORATION Repayments of Related Party Debt
GENELUX CORPORATION (GNLX) reported Repayments of Related Party Debt of $600.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2025-03-28
- GENELUX CORPORATION repayments of related party debt for the quarter ending 2023-12-31 was $0.00.
- GENELUX CORPORATION repayments of related party debt for the quarter ending 2023-09-30 was $0.00.
- GENELUX CORPORATION repayments of related party debt for the quarter ending 2023-06-30 was $200.00K.
- GENELUX CORPORATION repayments of related party debt for the quarter ending 2023-03-31 was $400.00K.
- GENELUX CORPORATION repayments of related party debt for fiscal 2023 was $600.00K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $0.00 derived: sum of 2 quarters · filed 2025-03-28 | $200.00K derived: sum of 3 quarters · filed 2025-03-28 | $600.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $200.00K derived: sum of 2 quarters · filed 2023-11-14 | $600.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $600.00K 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | $400.00K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |